Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge

  • Moreno, Sandra
  • Calvo Pinilla, Eva María
  • Devignot, S.
  • Weber, Friedemann
  • Ortego, Javier
  • Brun Torres, Alejandro
25 Pág., Many ruminant diseases of viral aetiology can be effectively prevented using appropriate vaccination measures. For diseases such as Rift Valley fever (RVF) the long inter-epizootic periods make routine vaccination programs unfeasible. Coupling RVF prophylaxis with seasonal vaccination programmes by means of multivalent vaccine platforms would help to reduce the risk of new RVF outbreaks., AB is supported by grants AGL2014-57430R and AGL2017-83226R from the Spanish Ministry of Science, and grant S2018/BAA 4370 from Comunidad de Madrid R&D in Technologies Program. JO is supported by grants AGL2014-57430R and AGL2017-82570R from the Spanish Ministry of Science and Innovation and European Union’s Horizon 2020 research and innovation program under grant proposal 727393-2. SMF is a recipient of a pre-doctoral fellowship program from the Spanish Ministry of Science and innovation. FW is supported by the CCHF Vaccine consortium that has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement no. 732732, and by the Swedish Research Council(Vetenskapsrådet, VR) section Research Environment, Infection Biology (contract number 2018-05766). The funding sources had no involvement in the study design nor in the writing of the report and the decision to submit the article for publication, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

A Machine Learning Framework to Identify the Correlates of Disease Severity in Acute Arbovirus Infection

  • Herder, Vanessa
  • Caporale, Marco
  • MacLean, Oscar A.
  • Pintus, Davide
  • Huang, Xinyi
  • Nomikou, Kyriaki
  • Palmalux, Natasha
  • Nichols, Jenna
  • Scivoli, Rosario
  • Boutell, Chris
  • Taggart, Aislynn
  • Allan, Jay
  • Malik, Haris
  • Ilia, Georgios
  • Gu, Quan
  • Ronchi, Gaetano Federico
  • Furnon, Wilhelm
  • Zientara, Stephan
  • Bréard, Emmanuel
  • Antonucci, Daniela
  • Capista, Sara
  • Giansante, Daniele
  • Cocco, Antonio
  • Mercante, Maria Teresa
  • Di Ventura, Mauro
  • Da Silva Filipe, Ana
  • Puggioni, Giantonella
  • Sevilla, Noemí
  • Stewart, Meredith E.
  • Ligios, Ciriaco
  • Palmarini, Massimo
Most viral diseases display a variable clinical outcome due to differences in virus strain virulence and/or individual host susceptibility to infection. Understanding the biological mechanisms differentiating a viral infection displaying severe clinical manifestations from its milder forms can provide the intellectual framework toward therapies and early prognostic markers. This is especially true in arbovirus infections, where most clinical cases are present as mild febrile illness. Here, we used a naturally occurring vector-borne viral disease of ruminants, bluetongue, as an experimental system to uncover the fundamental mechanisms of virus-host interactions resulting in distinct clinical outcomes. As with most viral diseases, clinical symptoms in bluetongue can vary dramatically. We reproduced experimentally distinct clinical forms of bluetongue infection in sheep using three bluetongue virus (BTV) strains (BTV-1IT2006, BTV-1IT2013 and BTV-8FRA2017). Infected animals displayed clinical signs varying from clinically unapparent, to mild and severe disease. We collected and integrated clinical, haematological, virological, and histopathological data resulting in the analyses of 332 individual parameters from each infected and uninfected control animal. We subsequently used machine learning to identify the key viral and host processes associated with disease pathogenesis. We identified five different fundamental processes affecting the severity of bluetongue: (i) virus load and replication in target organs, (ii) modulation of the host type-I IFN response, (iii) pro-inflammatory responses, (iv) vascular damage, and (v) immunosuppression. Overall, our study using an agnostic machine learning approach, can be used to prioritise the different pathogenetic mechanisms affecting the disease outcome of an arbovirus infection., The authors thank all team members of the Histology Research Service of University of Glasgow: Lynn Stevenson, Frazer Bell, Lynn Oxford, Jan Duncan, and Jessica Lee for the outstanding quality of their work in the histology lab. We also thank Giovanni Antonio Pilo for his invaluable support in the field work. The work would not have been possible without the invaluable help for animal care of Berardo De Dominicis, Doriano Ferrari, Massimiliano Caporale, Giampaolo Foschini in Teramo and the teams in Sassari, Italy. This study was funded by the Wellcome Trust (206369/Z/17/Z) and in part by the EU (H2020 PALE-Blu grant project No: 727393-2), the Italian Ministry of Health (RC IZS SA 02/16 and RC IZS SA 04/18), a Research Fellowship by the Deutsche Forschungsgemeinschaft (DFG; Project number 406109949) and the Medical Research Council (MC_UU_00034/5)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Correlates of disease severity in bluetongue as a model of acute arbovirus infection

  • Herder, Vanessa
  • Caporale, Marco
  • MacLean, Oscar A.
  • Pintus, Davide
  • Huang, Xinyi
  • Nomikou, Kyriaki
  • Palmalux, Natasha
  • Nichols, Jenna
  • Scivoli, Rosario
  • Boutell, Chris
  • Taggart, Aislynn
  • Allan, Jay
  • Malik, Haris
  • Ilia, Georgios
  • Gu, Quan
  • Ronchi, Gaetano Federico
  • Furnon, Wilhelm
  • Zientara, Stephan
  • Bréard, Emmanuel
  • Antonucci, Daniela
  • Capista, Sara
  • Giansante, Daniele
  • Cocco, Antonio
  • Mercante, Maria Teresa
  • Di Ventura, Mauro
  • Da Silva Filipe, Ana
  • Puggioni, Giantonella
  • Sevilla, Noemí
  • Stewart, Meredith E.
  • Ligios, Ciriaco
  • Palmarini, Massimo
30 Pág., Most viral diseases display a variable clinical outcome due to differences in virus strain virulence and/or individual host susceptibility to infection. Understanding the biological mechanisms differentiating a viral infection displaying severe clinical manifestations from its milder forms can provide the intellectual framework toward therapies and early prognostic markers. This is especially true in arbovirus infections, where most clinical cases are present as mild febrile illness. Here, we used a naturally occurring vector-borne viral disease of ruminants, bluetongue, as an experimental system to uncover the fundamental mechanisms of virus-host interactions resulting in distinct clinical outcomes. As with most viral diseases, clinical symptoms in bluetongue can vary dramatically. We reproduced experimentally distinct clinical forms of bluetongue infection in sheep using three bluetongue virus (BTV) strains (BTV-1IT2006, BTV-1IT2013 and BTV-8FRA2017). Infected animals displayed clinical signs varying from clinically unapparent, to mild and severe disease. We collected and integrated clinical, haematological, virological, and histopathological data resulting in the analyses of 332 individual parameters from each infected and uninfected control animal. We subsequently used machine learning to select the key viral and host processes associated with disease pathogenesis. We identified and experimentally validated five different fundamental processes affecting the severity of bluetongue: (i) virus load and replication in target organs, (ii) modulation of the host type-I IFN response, (iii) pro-inflammatory responses, (iv) vascular damage, and (v) immunosuppression. Overall, we showed that an agnostic machine learning approach can be used to prioritise the different pathogenetic mechanisms affecting the disease outcome of an arbovirus infection., This study was funded by the Wellcome Trust (206369/Z/17/Z to MP; https://wellcome.org/) and in part by the EU Horizon 2020 (H2020 PALE-Blu grant project No: 727393-2 to MP; https://research-and-innovation.ec.europa.eu/funding/funding-opportunities/funding-programmes-and-open-calls/horizon-2020_en), the Italian Ministry of Health (RC IZS SA 02/16 to GP, CL, RS, DP and RC IZS SA 04/18 16 to GP, CL, RS, DP; https://www.salute.gov.it/portale/home.html), a Research Fellowship by the Deutsche Forschungsgemeinschaft (DFG; Project number 406109949 to VH; https://www.dfg.de/en) and the Medical Research Council (MRC, MC_UU_00034/5 to MP; https://www.ukri.org/councils/mrc/). VH received a salary from the DFG funding., Peer reviewed